|
Volumn 49, Issue 6, 2016, Pages
|
Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CYCLOPROPANE DERIVATIVE;
DESVENLAFAXINE;
DULOXETINE;
MILNACIPRAN;
PLACEBO;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
VENLAFAXINE;
ADOLESCENT;
CHILD;
FEMALE;
HUMAN;
MAJOR DEPRESSION;
MALE;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
ADOLESCENT;
ANTIDEPRESSIVE AGENTS;
CHILD;
CYCLOPROPANES;
DEPRESSIVE DISORDER, MAJOR;
DESVENLAFAXINE SUCCINATE;
DULOXETINE HYDROCHLORIDE;
FEMALE;
HUMANS;
MALE;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS;
TREATMENT OUTCOME;
VENLAFAXINE HYDROCHLORIDE;
|
EID: 84996488301
PISSN: None
EISSN: 1414431X
Source Type: Journal
DOI: 10.1590/1414-431X20164806 Document Type: Article |
Times cited : (16)
|
References (0)
|